APA (7th ed.) Citation

J, L., D, E., JS, H., HR, S., A, K., & RF, S. (2023). Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage. Pharmaceutical statistics, 22(2), 236. https://doi.org/10.1002/pst.2268

Chicago Style (17th ed.) Citation

J, Labrenz, Edelmann D, Heitmann JS, Salih HR, Kopp-Schneider A, and Schlenk RF. "Performance of Phase-I Dose Finding Designs with and Without a Run-in Intra-patient Dose Escalation Stage." Pharmaceutical Statistics 22, no. 2 (2023): 236. https://doi.org/10.1002/pst.2268.

MLA (9th ed.) Citation

J, Labrenz, et al. "Performance of Phase-I Dose Finding Designs with and Without a Run-in Intra-patient Dose Escalation Stage." Pharmaceutical Statistics, vol. 22, no. 2, 2023, p. 236, https://doi.org/10.1002/pst.2268.